Mesoblast Valuation
MESO Stock | USD 19.52 0.03 0.15% |
At this time, the firm appears to be overvalued. Mesoblast secures a last-minute Real Value of $14.39 per share. The latest price of the firm is $19.52. Our model forecasts the value of Mesoblast from analyzing the firm fundamentals such as Shares Outstanding of 114.18 M, return on equity of -0.18, and Operating Margin of (12.49) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mesoblast's valuation include:
Price Book 4.8435 | Enterprise Value | Enterprise Value Ebitda (6.55) | Price Sales 420.6728 | Forward PE 454.5455 |
Overvalued
Today
Please note that Mesoblast's price fluctuation is slightly risky at this time. Calculation of the real value of Mesoblast is based on 3 months time horizon. Increasing Mesoblast's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mesoblast is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mesoblast Stock. However, Mesoblast's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 19.52 | Real 14.39 | Target 14.5 | Hype 18.92 | Naive 18.82 |
The intrinsic value of Mesoblast's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Mesoblast's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Mesoblast helps investors to forecast how Mesoblast stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mesoblast more accurately as focusing exclusively on Mesoblast's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mesoblast's intrinsic value based on its ongoing forecasts of Mesoblast's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mesoblast's closest peers.
Mesoblast Cash |
|
Mesoblast Valuation Trend
Knowing Mesoblast's actual value is paramount for traders when making sound investment determinations. Using both Mesoblast's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Mesoblast Total Value Analysis
Mesoblast is now projected to have valuation of 2.36 B with market capitalization of 1.14 B, debt of 118.92 M, and cash on hands of 85.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mesoblast fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
2.36 B | 1.14 B | 118.92 M | 85.5 M |
Mesoblast Investor Information
The book value of the company was now reported as 0.42. The company recorded a loss per share of 1.05. Mesoblast had not issued any dividends in recent years. The entity had 1:2 split on the 10th of January 2024. Based on the key indicators related to Mesoblast's liquidity, profitability, solvency, and operating efficiency, Mesoblast is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Mesoblast Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mesoblast has an asset utilization ratio of 0.88 percent. This suggests that the Company is making $0.00882 for each dollar of assets. An increasing asset utilization means that Mesoblast is more efficient with each dollar of assets it utilizes for everyday operations.Mesoblast Ownership Allocation
Mesoblast maintains a total of 114.18 Million outstanding shares. Roughly 98.55 % of Mesoblast outstanding shares are held by general public with 0.072 pct. owned by insiders and only 1.38 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Mesoblast Profitability Analysis
The company reported the previous year's revenue of 5.9 M. Net Loss for the year was (87.96 M) with loss before overhead, payroll, taxes, and interest of (47.42 M).About Mesoblast Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Mesoblast. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Mesoblast based exclusively on its fundamental and basic technical indicators. By analyzing Mesoblast's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Mesoblast's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mesoblast. We calculate exposure to Mesoblast's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mesoblast's related companies.Last Reported | Projected for Next Year | ||
Gross Profit | -31.7 M | -30.1 M | |
Pretax Profit Margin | (13.44) | (14.11) | |
Operating Profit Margin | (12.83) | (13.47) | |
Net Loss | (13.41) | (14.08) | |
Gross Profit Margin | (6.85) | (6.51) |
Mesoblast Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 986.7 M | |
Forward Price Earnings | 454.5455 |
Mesoblast Current Valuation Indicators
Mesoblast's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Mesoblast's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mesoblast, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mesoblast's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mesoblast's worth.When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.